Researcher Profiles

Return to member profile

Tamara Minko, PhD

Publications since 2011

Huang, X. Tao, Z. Praskavich, J. C. Jr Goswami, A. Al-Sharab, J. F. Minko, T. Polshettiwar, V. Asefa, T. Dendritic Silica Nanomaterials (KCC-1) with Fibrous Pore Structure Possess High DNA Adsorption Capacity and Effectively Deliver Genes In Vitro. Langmuir, In process, . (PMID: 25188675)

Peddada, L. Y. Garbuzenko, O. B. Devore, D. I. Minko, T. Roth, C. M. Delivery of antisense oligonucleotides using poly(alkylene oxide)-poly(propylacrylic acid) graft copolymers in conjunction with cationic liposomes. J Control Release, In process, . (PMID: 25192941)

Savla, R. Garbuzenko, O. B. Chen, S. Rodriguez-Rodriguez, L. Minko, T. Tumor-Targeted Responsive Nanoparticle-Based Systems for Magnetic Resonance Imaging and Therapy. Pharm Res, In process, . (PMID: 24919932)

Garbuzenko, O. B. Mainelis, G. Taratula, O. Minko, T. Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention. Cancer Biol Med, 11:44-55, . (PMID: 24738038, PMCID: PMC3969800)

Xie, X. Bansal, N. Shaik, T. Kerrigan, J. E. Minko, T. Garbuzenko, O. Abali, E. E. Johnson-Farley, N. Banerjee, D. Scotto, K. W. Bertino, J. R. A novel peptide that inhibits E2F transcription and regresses prostate tumor xenografts. Oncotarget, 5:901-907, . (PMID: 24658650, PMCID: PMC4011592)

Savla, R. Minko, T. Nanotechnology approaches for inhalation treatment of fibrosis. J Drug Target, 21:914-925, . (PMID: 23978292)

Shah, V. Taratula, O. G, O. B. Garbuzenko Taratula, O. R. Rodriguez-Rodriguez, L. Minko, T. Targeted Nanomedicine for Suppression of CD44 and Simultaneous Cell Death Induction in Ovarian Cancer: an Optimal Delivery of siRNA and Anticancer Drug. Clin Cancer Res, 19:6193-6204, . (PMID: 24036854, PMCID: PMC3846837)

Minko, T. Hatefi, A. Preface-tenth international nanomedicine and drug delivery symposium (NanoDDS'12). J Control Release, 171:259-260, . (PMID: 23954371)

Minko, T. Rodriguez-Rodriguez, L. Pozharov, V. Nanotechnology approaches for personalized treatment of multidrug resistant cancers. Adv Drug Deliv Rev, 65:1880-1895, . (PMID: 24120655)

Minko, T. Nanotechnology and drug resistance. Adv Drug Deliv Rev, 65:1665-1666, . (PMID: 24177352)

Xie, X. Kerrigan, J. E. Minko, T. Garbuzenko, O. Lee, K. C. Scarborough, A. Abali, E. E. Budak-Alpdogan, T. Johnson-Farley, N. Banerjee, D. Scotto, K. W. Bertino, J. R. Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer. Cancer Biol Ther, 14:742-751, . (PMID: 23792570)

Ivanova, V. Garbuzenko, O. B. Reuhl, K. R. Reimer, D. C. Pozharov, V. P. Minko, T. Inhalation Treatment of Pulmonary Fibrosis by Liposomal Prostaglandin E2. Eur J Pharm Biopharm, 84:335-344, . (PMID: 23228437, PMCID: PMC3660419)

Taratula, O. Kuzmov, A. Shah, M. Garbuzenko, O. B. Minko, T. Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA. J Control Release, In process, . (PMID: 23648833, PMCID: PMC3766401)

Mainelis, G. Seshadri, S. Garbuzenko, O. B. Han, T. Wang, Z. Minko, T. Characterization and Application of a Nose-Only Exposure Chamber for Inhalation Delivery of Liposomal Drugs and Nucleic Acids to Mice. J Aerosol Med Pulm Drug Deliv, In process, . (PMID: 23530772)

Shah, V. Taratula, O. Garbuzenko, O. B. Patil, M. L. Savla, R. Zhang, M. Minko, T. Genotoxicity of Different Nanocarriers: Possible Modifications for the Delivery of Nucleic Acids. Curr Drug Discov Technol, In process, . (PMID: 22564170)

Sheihet, L. Garbuzenko, O. B. Bushman, J. Gounder, M. K. Minko, T. Kohn, J. Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor. Eur J Pharm Sci, 45:320-329, . (PMID: 22155544)

Zhang, M. Garbuzenko, O. B. Reuhl, K. R. Rodriguez-Rodriguez, L. Minko, T. Two-in-one: combined targeted chemo and gene therapy for tumor suppression and prevention of metastases. Nanomedicine (Lond), 7:185-197, . (PMID: 22339132)

Nadler-Milbauer, M. Apter, L. Haupt, Y. Haupt, S. Barenholz, Y. Minko, T. Rubinstein, A. Synchronized release of Doxil and Nutlin-3 by remote degradation of polysaccharide matrices and its possible use in the local treatment of colorectal cancer. J Drug Target, 19:859-873, . (PMID: 22082104)

Taratula, O. Garbuzenko, O. B. Chen, A. M. Minko, T. Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA. J Drug Target, 19:900-914, . (PMID: 21981718)

Dayan, N. Shah, V. Minko, T. Preliminary evaluation of the genotoxic potential of a hydrophilic polymer with three preservation systems. Int J Cosmet Sci, 33:497-502, . (PMID: 21696404)

Savla, R. Taratula, O. Garbuzenko, O. Minko, T. Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer. J Control Release, 153:16-22, . (PMID: 21342659)

Patil, M. L. Zhang, M. Minko, T. Multifunctional triblock Nanocarrier (PAMAM-PEG-PLL) for the efficient intracellular siRNA delivery and gene silencing. ACS Nano, 5:1877-1887, . (PMID: 21322531, PMCID: PMC3062392)

Betigeri, S. Zhang, M. Garbuzenko, O. Minko, T. Non-viral systemic delivery of siRNA or antisense oligonucleotides targeted to Jun N-terminal kinase 1 prevents cellular hypoxic damage. Drug Deliv Transl Res, 1:13-24, . (PMID: 21461383, PMCID: PMC3063508)

Dayan, N. Shah, V. Minko, T. Genotoxic potential evaluation of a cosmetic insoluble substance by the micronuclei assay. J Cosmet Sci, 62:29-39, . (PMID: 21443843)

Taratula, O. Garbuzenko, O. Savla, R. Wang, Y. A. He, H. Minko, T. Multifunctional Nanomedicine Platform for Cancer Specific Delivery of siRNA by Superparamagnetic Iron Oxide Nanoparticles-Dendrimer Complexes. Curr Drug Deliv, 8:59-69, . (PMID: 21034421)